Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICE vs CapOx in Gemcitabine-Resistant Pancreatic Cancer
NCT01042028Phase 2Terminated
- Sponsor
- Pfeiffer Pharmaceuticals
- Start
- Jan 2010
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in pancreatic cancer (PC), sponsored by Pfeiffer Pharmaceuticals. Started Jan 2010; status: terminated.
02
Drugs
everolimus
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT01042028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01042028.